English press releases

IFF Declares Dividend for Fourth Quarter 2025

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its...

Rimini Street Announces Fiscal Third Quarter 2025 Financial and Operating Results

Third Quarter Financial Highlights Include: Remaining Performance Obligations (RPO) of $611.2 million, up 6.4% from the prior year Adjusted Calculated Billings of $63.9 million, up...

Canva Launches Creative Operating System

Next era of Canva combines a supercharged Visual Suite, world-first design AI, and powerful tools to grow your brand Canva Design Model: World-first AI model...

Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents

BAAR, Switzerland–(BUSINESS WIRE)– Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy),...

Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers

An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat...

Novotech Maps Global Growth in Radiopharmaceutical Trials

SYDNEY–(BUSINESS WIRE)– Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, today released a new white paper detailing the rapid rise of...

Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year

First Half Revenue Declined 3.9% at Constant Exchange Rate (CER), -6.9% at Actual Exchange Rates (AER), Impacted by Generic Erosion of VYVANSE® and FX Headwind...

R2 Joins Ant International to Expand Credit Access for SMEs in LATAM

The investment will enable both companies to integrate their expertise to improve credit access for small and medium-sized enterprises (SMEs) in a region facing a...

Rimini Street to Host Investor Day 2025 on December 3, 2025

The Company will share its opportunities and unique solutions in enterprise software support and its ownership of the Agentic AI ERP market, present its sales...

Phenom Named Strategic Leader in 2025 Fosway 9-Grid™ for Talent & People Success for Second Consecutive Year

Positioning Recognises Phenom Applied AI LONDON–(BUSINESS WIRE)– Phenom, an applied AI company that helps organizations hire faster, develop better and retain longer, has been named...

Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®

SAINT-PREX, Switzerland–(BUSINESS WIRE)– As part of our ongoing transformation to sharpen our focus, we have decided to explore strategic options for Rebyota® (faecal microbiota, live...

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

LONDON & NEW YORK–(BUSINESS WIRE)– Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today...

Ant Group’s AQ Tops China’s AI-Native Healthcare Apps, Launching New Features for Chronic Disease and Elderly Care

HANGZHOU, China–(BUSINESS WIRE)– Ant Group’s AI healthcare service AQ is now among China’s top 7 AI-native apps and the only healthcare app on the list,...

Logitech Announces Q2 Fiscal Year 2026 Results

Operational Excellence and Strategic Priorities Drive Strong Second Quarter LAUSANNE, Switzerland & SAN JOSE, Calif.–(BUSINESS WIRE)– SIX Swiss Exchange Ad hoc announcement pursuant to Art....

Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies

Partnership combines Merck’s chemistry and organoid expertise with Promega’s assay technologies Aims to improve researcher access to disease-relevant cell models Strengthens Merck’s leadership in next-generation...